Choose the experimental features you want to try

This document is an excerpt from the EUR-Lex website

Document 32013D0262

    2013/262/EU: Commission Implementing Decision of 4 June 2013 amending Implementing Decision 2012/715/EU establishing a list of third countries with a regulatory framework applicable to active substances for medicinal products for human use and the respective control and enforcement activities ensuring a level of protection of public health equivalent to that in the Union Text with EEA relevance

    OJ L 152, 5.6.2013, p. 52–53 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

    This document has been published in a special edition(s) (HR)

    Legal status of the document In force

    ELI: http://data.europa.eu/eli/dec_impl/2013/262/oj

    5.6.2013   

    EN

    Official Journal of the European Union

    L 152/52


    COMMISSION IMPLEMENTING DECISION

    of 4 June 2013

    amending Implementing Decision 2012/715/EU establishing a list of third countries with a regulatory framework applicable to active substances for medicinal products for human use and the respective control and enforcement activities ensuring a level of protection of public health equivalent to that in the Union

    (Text with EEA relevance)

    (2013/262/EU)

    THE EUROPEAN COMMISSION,

    Having regard to the Treaty on the Functioning of the European Union,

    Having regard to Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community Code relating to medicinal products for human use (1), and in particular Article 111b(1) thereof,

    Whereas:

    (1)

    In accordance with Article 111b(1) of Directive 2001/83/EC a third country may request the Commission to assess whether its regulatory framework applicable to active substances exported to the Union and the respective control and enforcement activities ensure a level of protection of public health equivalent to that of the Union in order to be included in a list of third countries ensuring an equivalent level of protection of public health.

    (2)

    Japan requested, by letter dated 6 December 2012, to be listed in accordance with Article 111b(1) of Directive 2001/83/EC. The equivalence assessment by the Commission confirmed that the requirements of that Article were fulfilled.

    (3)

    Commission Implementing Decision 2012/715/EU of 22 November 2012 establishing a list of third countries with a regulatory framework applicable to active substances for medicinal products for human use and the respective control and enforcement activities ensuring a level of protection of public health equivalent to that in the Union, in accordance with Directive 2001/83/EC of the European Parliament and of the Council (2) should be amended accordingly,

    HAS ADOPTED THIS DECISION:

    Article 1

    The Annex to Implementing Decision 2012/715/EU is replaced by the text set out in the Annex to this Decision.

    Article 2

    This Decision shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

    Done at Brussels, 4 June 2013.

    For the Commission

    The President

    José Manuel BARROSO


    (1)   OJ L 311, 28.11.2001, p. 67.

    (2)   OJ L 325, 23.11.2012, p. 15.


    ANNEX

    ‘ANNEX

    Third country

    Remarks

    Australia

     

    Japan

     

    Switzerland’

     


    Top